Chemotherapy accelerates immune-senescence and functional impairments of Vδ2pos T cells in elderly patients affected by liver metastatic colorectal cancer

γδ TCR ligands: the quest to solve a 500-million-year-old mystery

(2019) Benjamin E. Willcox et al.   NATURE IMMUNOLOGY

The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer cells represents a therapeutic target in haploidentical haematopoietic stem cell transplantation

(2018) Alessandra Roberto et al.   HAEMATOLOGICA

Unconventional T Cell Targets for Cancer Immunotherapy

(2018) Dale I. Godfrey et al.   IMMUNITY

The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer cells represents a therapeutic target in haploidentical haematopoietic stem cell transplantation

(2018) Alessandra Roberto et al.   HAEMATOLOGICA

Mapping of γ/δ T cells reveals Vδ2+ T cells resistance to senescence

(2018) Weili Xu et al.   EBioMedicine

Markers of T Cell Senescence in Humans

(2017) Weili Xu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival

(2017) Matteo Donadon et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Markers of cellular senescence. Telomere shortening as a marker of cellular senescence

(2016) Alexandra Bernadotte et al.   Aging-US

Ageing as an Important Risk Factor for Cancer

(2016) KAREL SMETANA JR. et al.   ANTICANCER RESEARCH

γδ T cells in cancer immunotherapy

(2016) Chang Zou et al.   Oncotarget

CD28 Negative T Cells: Is Their Loss Our Gain?

(2014) D. Mou et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells

(2014) Alessio Lanna et al.   NATURE IMMUNOLOGY

From “truly naïve” to “exhausted senescent” T cells: When markers predict functionality

(2013) Anis Larbi et al.   CYTOMETRY PART A

Prognostic value of CD57+ T lymphocytes in the peripheral blood of patients with advanced gastric cancer

(2008) Junji Akagi et al.   International Journal of Clinical Oncology